-At least 15 million people aged 13 to 15 use e-cigarettes globally, with young people on average nine times more likely to vape than adults in countries with data, the World Health Organization said ...
Richmond is still the tobacco capital of the world,” said James Xu of his new locally based vaping device maker Fav, which ...
Achieve Life Sciences shares jumped after the company said it got a priority voucher for its treatment of nicotine dependence stemming from e-cigarettes and vaping. The stock was up by about one-third ...
Background Displaying signage about the minimum legal age (MLA) for tobacco, including e-cigarette sales in retail stores, is ...
FDA accepts Achieve Life Sciences' NDA for cytisinicline in smoking cessation. Promising vaping results boost market ...
Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review Pathway One of Only Nine Therapies Chosen for the FDA’s Inaugural National ...
Background Smoke-free and aerosol-free households (SAFHs) reduce exposure to secondhand smoke and aerosol and support ...
Alternatively, you may access the live conference call by dialing 888-396-8049 (U.S. & Canada) or 416-764-8646 (International) and referencing conference ID 13756406. A webcast replay will be ...
Achieve Life Sciences announced that the U.S. Food and Drug Administration has awarded its investigational cytisinicline therapy a Commissioner's National Priority Voucher, enabling expedited review ...
The company is returning to the U.S. market with fresh capital to focus on its original mission: helping adult smokers quit ...
Helen DeWitt’s bewildering co-written novel, “Your Name Here,” took almost 20 years to publish, a process that nearly drove ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback